Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877251322808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Rong-Ji Xue und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Complement C1q, Amyloid beta-Peptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholar Foundation of Shandong Province.
Themen: Demenz
Abstract (Originalsprache)
Background
C1q is a promoter of the classical pathway of complement and its massive expression may be associated with the development of Alzheimer's disease (AD). However, the relationships between C1q and the major pathological challenges, including amyloid-β (Aβ) and tau deposition, remain undetermined in the preclinical AD phase.
Objective
This study aims to investigate the connections between plasma C1q and CSF AD biomarkers.
Methods
The cognitively intact participants (N = 1264) from the Chinese Alzheimer's Biomarker and LifestylE (CABLE) study were categorized into four groups, including Stage 0 [normal Amyloid-β 1–42 (Aβ 1–42 ), Phosphorylated-tau (P-tau) and Total-tau (T-tau)], Stage 1 (abnormal Aβ 1–42, but normal P-tau or T-tau), Stage 2 (abnormal Aβ 1–42 and abnormal P-tau or T-tau), and suspected non-Alzheimer disease pathology (SNAP) (abnormal P-tau or T-tau, but normal amyloid levels). The changes in plasma C1q levels among these groups and the correlation between C1q levels and cerebrospinal fluid (CSF) AD biomarkers were performed.
Results
The results demonstrated plasma C1q levels are lower in Stage 0 (p = 0.010) and SNAP (p < 0.001) compared with Stage 1. A significant association between C1q levels and CSF AD pathology, including Aβ 1–42 (β = −0.143, p < 0.001), Aβ 1–42 /Aβ 1–40 (β = −0.173, p < 0.001), P-tau/Aβ 1–42 (β = 0.156, p < 0.001), and T-tau/Aβ 1–42 (β = 0.130, p < 0.001) has been identified.
Conclusions
The current research elucidates a positive correlation between elevated plasma C1q levels and CSF Aβ pathology, with C1q amplifying concomitantly with the pathological and clinical progression of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
- Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China.
- Department of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Qingdao, China.
- Department of Neurology, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
- Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.
ORCID-Profile: Rong-Ji Xue, Pei-Yang Gao, Yan-Ming Chen, Bao-Lin Han, Yi-Ming Huang, Yin-Chu Mi, Rui-Ping Cui, Yu-Jing Lin, Zuo-Teng Wang, Chen-Chen Tan, Lan Tan
Förderung
- National Natural Science Foundation of China
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Xue, R. J., Gao, P. Y., Chen, Y. M., Liu, Y., Han, B. L., Huang, Y. M., Mi, Y. C., Cui, R. P., Lin, Y. J., Wang, Z. T., Tan, C. C., Ou, Y. N., & Tan, L. (2025). Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251322808
Vancouver
Xue RJ, Gao PY, Chen YM, Liu Y, Han BL, Huang YM, et al. Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251322808
BibTeX
@article{Xue2025,
author = {Xue, Rong-Ji and Gao, Pei-Yang and Chen, Yan-Ming and Liu, Ying and Han, Bao-Lin and Huang, Yi-Ming and Mi, Yin-Chu and Cui, Rui-Ping and Lin, Yu-Jing and Wang, Zuo-Teng and Tan, Chen-Chen and Ou, Ya-Nan and Tan, Lan},
title = {Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: The CABLE study},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877251322808}
}
EUVIMED